Nurten Yigit

1.6k citations

29 papers · 864 indexed · h-index 15

Co-authors: Jo Vandesompele Frank Speleman Anne De Paepe Tom Van Maerken Els De Smet Jean‐Christophe Marine Joëlle Vermeulen Katleen De Preter
Topics: Neuroblastoma Research and Treatments (12 papers)RNA modifications and cancer (6 papers)Cancer-related molecular mechanisms research (4 papers)
Cited by: Neurology Cancer Research Oncology
Journals: Nucleic Acids Research JNCI Journal of the National Cancer Institute Cancer Research
Partner nations: Belgium United States Germany

In The Last Decade

Nurten Yigit

29 papers receiving 851 citations

Peers

Countries citing papers authored by Nurten Yigit

Since Specialization

Citations

This map shows the geographic impact of Nurten Yigit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nurten Yigit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nurten Yigit more than expected).

Fields of papers citing papers by Nurten Yigit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nurten Yigit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nurten Yigit. The network helps show where Nurten Yigit may publish in the future.

Co-authorship network of co-authors of Nurten Yigit

This figure shows the co-authorship network connecting the top 25 collaborators of Nurten Yigit. A scholar is included among the top collaborators of Nurten Yigit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nurten Yigit. Nurten Yigit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploration of neuroblastoma xenograft models for tumor extracellular RNA profiling in murine blood plasma 2023 ·Ghent University Academic Bibliography (Ghent University) ·(unknown),(unknown),Jasper Anckaert,Anneleen Decock,(unknown),Kaat Durinck,Liselot Mus,Justine Nuytens,(unknown),(unknown),Frank Speleman,(unknown),Kimberly Verniers,Nurten Yigit,Jo Vandesompele,Bram De Wilde,Tom Van Maerken	1
2	mTOR Inhibition Enhances Delivery and Activity of Antisense Oligonucleotides in Uveal Melanoma Cells 2023 ·Nucleic Acid Therapeutics ·(unknown),(unknown),Boél De Paepe,(unknown),(unknown),Jasper Anckaert,Nurten Yigit,Justine Nuytens,Rudy Van Coster,Sven Eyckerman,Koen Raemdonck,Pieter Mestdagh	2
3	Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation 2023 ·NAR Cancer ·Alan Van Goethem,(unknown),Nurten Yigit,Celine Everaert,Myrthala Moreno‐Smith,Sanjeev A. Vasudevan,Fjoralba Zeka,(unknown),Eveline Barbieri,Frank Speleman,Pieter Mestdagh,Jason M. Shohet,Jo Vandesompele,Tom Van Maerken	3
4	A 3′‐end capture sequencing method for high‐throughput targeted gene expression profiling 2022 ·Biotechnology Journal ·Eric James de Bony,(unknown),Nurten Yigit,Jasper Anckaert,Celine Everaert,(unknown),Kimberly Verniers,Willem van Snippenberg,Wim Trypsteen,Pieter Mestdagh	1
5	SMARTer single cell total RNA sequencing 2019 ·Nucleic Acids Research ·Karen Verboom,Celine Everaert,Nathalie Bolduc,Kenneth J. Livak,Nurten Yigit,Dries Rombaut,Jasper Anckaert,Simon Ming‐Yuen Lee,Morten T. Venø,Jørgen Kjems,Frank Speleman,Pieter Mestdagh,Jo Vandesompele	35
6	Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes 2019 ·Scientific Reports ·Dries Rombaut,Hua‐Sheng Chiu,Bieke Decaesteker,Celine Everaert,Nurten Yigit,Agathe Peltier,Isabelle Janoueix‐Lerosey,Christoph Bartenhagen,Matthias Fischer,Stephen S. Roberts,Nicky D’Haene,Katleen De Preter,Frank Speleman,Geertrui Denecker,Pavel Sumazin,Jo Vandesompele,Steve Lefever,Pieter Mestdagh	10
7	Prognostic and Therapeutic Implications of Circulating Androgen Receptor Gene Copy Number in Prostate Cancer Patients Using Droplet Digital Polymerase Chain Reaction 2017 ·Clinical Genitourinary Cancer ·(unknown),Tom Claeys,Bert Dhondt,Filip Poelaert,Matthijs Vynck,Nurten Yigit,Olivier Thas,Piet Ost,Jo Vandesompele,Nicolaas Lumen,Candy Kumps	7
8	Depletion of tRNA-halves enables effective small RNA sequencing of low-input murine serum samples 2016 ·Scientific Reports ·Alan Van Goethem,Nurten Yigit,Celine Everaert,Myrthala Moreno‐Smith,Liselot Mus,Eveline Barbieri,Frank Speleman,Pieter Mestdagh,Jason M. Shohet,Tom Van Maerken,Jo Vandesompele	11
9	Functional Analysis of the p53 Pathway in Neuroblastoma Cells Using the Small-Molecule MDM2 Antagonist Nutlin-3 2011 ·Molecular Cancer Therapeutics ·Tom Van Maerken,Ali Rihani,Daniel Dreidax,Sarah De Clercq,Nurten Yigit,Jean‐Christophe Marine,Frank Westermann,Anne De Paepe,Jo Vandesompele,Frank Speleman	61
10	Antitumor Activity of the Selective MDM2 Antagonist Nutlin-3 Against Chemoresistant Neuroblastoma With Wild-Type p53 2009 ·JNCI Journal of the National Cancer Institute ·Tom Van Maerken,Liesbeth Ferdinande,(unknown),Irina Lambertz,Nurten Yigit,(unknown),Ali Rihani,Martin Michaelis,Jindřich Činátl,Claude Cuvelier,Jean‐Christophe Marine,Anne De Paepe,Marc Bracke,Frank Speleman,Jo Vandesompele	99
11	Aberrant methylation of candidate tumor suppressor genes in neuroblastoma 2008 ·Cancer Letters ·Jasmien Hoebeeck,Evi Michels,Filip Pattyn,Valérie Combaret,Joëlle Vermeulen,Nurten Yigit,Claire Hoyoux,Geneviève Laureys,Anne De Paepe,Frank Speleman,Jo Vandesompele	48
12	EVI1 overexpression in t(3;17) positive myeloid malignancies results from juxtaposition of EVI1 to the MSI2 locus at 17q22 2008 ·Haematologica ·An De Weer,Frank Speleman,Barbara Cauwelier,Nadine Van Roy,Nurten Yigit,Bruno Verhasselt,Barbara De Moerloose,Yves Benoît,L. Noens,Dominik Selleslag,Éric Lippert,Stéphanie Struski,Christian Bastard,Anne De Paepe,Peter Vandenberghe,A Hagemeijer,Nicole Dastugue,Bruce Poppe,(unknown)	19
13	Small-Molecule MDM2 Antagonists as a New Therapy Concept for Neuroblastoma 2006 ·Cancer Research ·Tom Van Maerken,Frank Speleman,Joëlle Vermeulen,Irina Lambertz,Sarah De Clercq,Els De Smet,Nurten Yigit,(unknown),Jan Philippé,Anne De Paepe,Jean‐Christophe Marine,Jo Vandesompele	120
14	High resolution tiling‐path BAC array deletion mapping suggests commonly involved 3p21‐p22 tumor suppressor genes in neuroblastoma and more frequent tumors 2006 ·International Journal of Cancer ·Jasmien Hoebeeck,Evi Michels,Björn Menten,Nadine Van Roy,Angelika Eggert,Alexander Schramm,Katleen De Preter,Nurten Yigit,Els De Smet,Anne De Paepe,Geneviève Laureys,Jo Vandesompele,Frank Speleman	18
15	The von Hippel‐Lindau tumor suppressor gene expression level has prognostic value in neuroblastoma 2006 ·International Journal of Cancer ·Jasmien Hoebeeck,Jo Vandesompele,Helén Nilsson,Katleen De Preter,Nadine Van Roy,Els De Smet,Nurten Yigit,Anne De Paepe,Geneviève Laureys,Sven Påhlman,Frank Speleman	12
16	HOXA gene cluster rearrangement in a t(7;9)(p15;q34) in a child with MDS 2005 ·Cancer Genetics and Cytogenetics ·Bruce Poppe,Nurten Yigit,Barbara De Moerloose,Anne De Paepe,Yves Benoît,Frank Speleman	3
17	Positional and functional mapping of a neuroblastoma differentiation gene on chromosome 11 2005 ·BMC Genomics ·Katleen De Preter,Jo Vandesompele,Björn Menten,Philippa Carr,Heike Fiegler,Anders Edsjö,Nigel P. Carter,Nurten Yigit,Wim Waelput,Nadine Van Roy,Scott Bader,Sven Påhlman,Frank Speleman	16
18	PAX5/IGH rearrangement is a recurrent finding in a subset of aggressive B‐NHL with complex chromosomal rearrangements 2005 ·Genes Chromosomes and Cancer ·Bruce Poppe,Pascale De Paepe,Lucienne Michaux,Nicole Dastugue,Christian Bastard,Christian Herens,(unknown),Francesco Cavazzini,Nurten Yigit,Heidi Van Limbergen,Anne De Paepe,Marleen Praet,Chris De Wolf‐Peeters,Iwona Włodarska,Frank Speleman	55
19	Rapid detection of VHL exon deletions using real-time quantitative PCR 2004 ·Laboratory Investigation ·Jasmien Hoebeeck,Rob B. van der Luijt,Bruce Poppe,Els De Smet,Nurten Yigit,Kathleen Claes,(unknown),(unknown),Anne De Paepe,Frank Speleman,Jo Vandesompele	80
20	Molecular characterization of a t(2;3)(p23;q26): A recurrent translocation involving the EVI1 gene 2001 ·Ghent University Academic Bibliography (Ghent University) ·Bruce Poppe,Nurten Yigit,Peter Marynen,A Hagemeijer,Heidi Van Limbergen,Barbara Smet,Anne De Paepe,Frank Speleman	2

About Nurten Yigit

Nurten Yigit is a scholar working on Neurology, Cancer Research and Molecular Biology, having authored 29 papers that have together received 864 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (12 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Neurology (343 citations), Cancer Research (282 citations) and Oncology (264 citations). Nurten Yigit has collaborated with scholars based in Belgium, United States and Germany. Frequent co-authors include Jo Vandesompele, Frank Speleman, Anne De Paepe, Tom Van Maerken, Els De Smet, Jean‐Christophe Marine, Joëlle Vermeulen, Katleen De Preter, Bruce Poppe and Irina Lambertz. Their work appears in journals such as Nucleic Acids Research, JNCI Journal of the National Cancer Institute and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact